This contract expires in 109 days (Sep 29, 2026).
UNIVERSITY OF MARYLAND, BALTIMORE - CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR
Key Details
Description
CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR
Context & Analysis
On Feb 20, 2026, Department of Health and Human Services obligated $460,000 to UNIVERSITY OF MARYLAND, BALTIMORE for characterizing albumin-bound nanoparticle drugs using wnmr. The award is classified under NAICS 334516 — ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BALTIMORE, MD. The contract is scheduled through Sep 29, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 334516 — related awards are listed below.
Contractor Information
Similar Awards
PURHCASE ORDER FOR COST PER TEST AGREEMENT FOR CLINTON, WEWOKA, LAWTON AND CLAREMORE LABORATORIES.
SIEMENS HEALTHCARE DIAGNOSTICS INC.
$6.7M
PURHCASE ORDER FOR COST PER TEST AGREEMENT FOR CLINTON, WEWOKA, LAWTON AND CLAREMORE LABORATORIES.
SIEMENS HEALTHCARE DIAGNOSTICS INC.
$6.2M
CHROMATOGRAPHY DATA SYSTEM FOR OMPSLO SLEP (VARIOUS SITES)
WATERS TECHNOLOGIES CORPORATION
$2.1M
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT/LEASE AGREEMENT.
QUIDELORTHO SALES COMPANY, LLC
$1.6M
PROVIDE VITROS SERVICE AND REAGENTS FOR HOPI HEALTH CARE CENTER
QUIDELORTHO SALES COMPANY, LLC
$1.2M
Stay Updated
Get notified about new opportunities matching your interests.